 AUSTIN, Texas, May 18, 2022 GLOBE NEWSWIRE -- Plus Therapeutics, Inc. Nasdaq: PSTV, a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, announced today that Marc Hedrick, M.D., President and Chief Executive Officer, will present virtually at the 2022 H.C. Wainwright Global Investment Conference being held May 23-26, 2022. 